Location: Home
  • search
  • go
  • News
  • 11/5/2025Senior CSPC Executive Fined CNY 5M for Insider Trading
  • 11/5/2025Bayer Deepens Investment in China's Booming Biopharma Sector
  • 11/5/2025China to Expand Use of Artificial Intelligence Across Health Sector by...
  • 11/5/2025CDE Grants Breakthrough Therapy Designation to Ivonescimab for Triple-...
  • 11/5/2025US Dollar Funds Make a Comeback in China's Innovative Drug Market: VBD...
  • 11/5/2025TransThera Signs up to US$881.5M Global Deal with Neurocrine for NLRP...
  • 11/5/2025Merck Secures $700M Funding from Blackstone for TROP2-Targeting ADC C...
  • 11/5/2025CSL Behring Expands Partnership with Baiyang Pharma for Albumin Produc...
  • 11/4/2025China's BMI Fund Maintains Strong Surplus in First Three Quarters of 2...
  • 11/4/2025NHSA Introduces New Measure to Strengthen Intelligent Oversight of Exc...
  • 11/4/2025CDE Invites Comments on the Draft Technical Guidelines for Dose Extrap...
  • 11/4/2025CDE Seeks Comments on the 100th Batch of Reference Formulations for Ch...
  • 11/4/2025Lepu Licenses GLP-1/GIP/FGF21 Agonist MWN105 to Sidera in US$1.05B Dea...
  • 11/4/2025Huadong Medicine Initiates Phase I Trial of CDH17-Targeting ADC HDM201...
  • 11/4/2025NovaBridge Biosciences (I-Mab) Files for Hong Kong IPO
  • 11/4/2025Alebund Pharma's Hong Kong IPO Application Accepted
  • 11/4/2025Lupeng Pharma's Hong Kong IPO Application Accepted
  • 11/4/2025China to Include HPV Vaccines in National Immunization Program
  • 11/4/2025CStone Receives NMPA IND Approval for Phase II Trials of CS2009
  • 11/4/2025Everest Acquires Exclusive Greater China and Other Asian Country Right...
  • 11/4/2025Abbisko Begins Phase II Trial of Oral PD-L1 Inhibitor ABSK043 in Combo...
  • 11/4/2025Genscript Secures NMPA IND Clearance for Second Bispecific ADC GenSci1...
  • 10/31/2025CDE Invites Comment on Implementation Guidance for ICH Q8, Q9 and Q10 ...
  • 10/31/2025GC Cell Licenses IASO Biotech's Multiple Myeloma CAR-T Therapy for Kor...
  • 10/31/2025Haleon Gains Momentum in China as U.S. Sales Remain Weak
  • 10/31/2025China Overhauls Drug Procurement and Reimbursement Framework to Balanc...
  • 10/31/2025China Adds Novel Drugs Catalog to National BMI Talks for the First Tim...
  • 10/31/2025Lumosa's Stroke Drug Achieves Phase IIb Success in China
  • 10/31/2025Junshi's Toripalimab Becomes First Immunotherapy Approved for NPC in C...
  • 10/31/2025Roche Strikes Over $1B Global Licensing Deal with Qyuns Therapeutics
  • Page:7/58 Total number of articles:1718: [First][<<] [5] [6] [7] [8] [9] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group